Literature DB >> 23437895

Sistani population: a different spectrum of β-thalassemia mutations from other ethnic groups of Iran.

Ebrahim Miri-Moghaddam1, Azita Zadeh-Vakili, Abbas Nikravesh, Shohreh Sanei Sistani, Mehrnaz Naroie-Nejad.   

Abstract

This study aimed to characterize the molecular spectrum of β-thalassemia (β-thal) mutations and evaluate the services available for prenatal diagnosis (PND) among the Sistani population of Iran. Mutations were analyzed with amplification refractory mutation system (ARMS), gap-polymerase chain reaction (gap-PCR), multiplex ligation-dependent probe amplification (MLPA) analysis and direct sequencing. Fetal diagnosis was also confirmed by linkage analysis. Over a 9-year period (2002-2011), 405 at-risk Sistani couples were referred for mutation analysis and/or PND. Of the referred couples, 18.5% had one to three affected children with β-thal major (β-TM) and the remainder had no children or were not married. Most of the couples (73.3%) lived in urban areas and the rate of consanguineous marriage was 76.8%. Twenty-one mutations were identified, of which the most frequent ones were IVS-I-5 (G>C) with a frequency of 74.1%, followed by codon 15 G>A (5.0%), codon -88 (C>T) (3.8%), IVS-II-1 (G>A) (3.4%), codons 8/9 (+G) (2.9%) and IVS-I-1 (G>T) (2.7%), which accounted for about 91.9% of the total β-thal mutations for this region. Furthermore, fetal DNA was obtained from chorionic villus sampling (CVS) for 266 pregnant women and 68 (25.5%) fetuses were diagnosed as affected. In summary, β-thal mutations are very heterogeneous and significantly different from those found in other parts of Iran and are similar to those of Pakistani and Indian populations. These results could greatly facilitate timely and accurate PND.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23437895     DOI: 10.3109/03630269.2013.769886

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

1.  High School Knowledge and Attitudes towards Thalassemia in Southeastern Iran.

Authors:  Ebrahim Miri-Moghaddam; Eisa Motaharitabar; Leila Erfannia; Alireza Dashipour; Marziyeh Houshvar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

2.  Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Authors:  Ebrahim Miri-Moghaddam; Sara Bahrami; Majid Naderi; Ali Bazi; Morteza Karimipoor
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

3.  Spectrum of alpha-globin gene mutations among premarital Baluch couples in southeastern Iran.

Authors:  Ebrahim Miri-Moghaddam; Abass Nikravesh; Negin Gasemzadeh; Mahin Badaksh; Nahid Rakhshi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

4.  Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.

Authors:  Mehrdad Sadeghi Haj; Abbas Nikravesh; Majid Pahlevan Kakhki; Nahid Rakhshi
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

5.  Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and β- Thalassemia Minor.

Authors:  Ebrahim Miri-Moghaddam; Narjes Sargolzaie
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

6.  Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran.

Authors:  Maryam Yaghobi; Ebrahim Miri-Moghaddam; Naderi Majid; Ali Bazi; Ali Navidian; Asiyeh Kalkali
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.